Not provided
Not provided
Not provided
Not provided
Not provided
Funding ran out_difficulties with study product (delays in authorization).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Louise & Alan Edwards Foundation | UNKNOWN |
| McGill University | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Neuropathic pain is one form of chronic pain lacking effective pharmacotherapy. Interest in the role of complementary and alternative medicine is growing and diet is at the forefront of the search for alternative treatments for pain. Soy protein is one of the most promising dietary ingredients tested for its pain-relieving properties. Results from animal studies show that soy-enriched diets reduce pain due to nerve injury. The purpose of this study is to determine the effects of soy protein supplementation on facial pain.
Neuropathic pain is a complex disorder with mixed results in response to pain medication due to a high degree of variability between patients. To address this issue, we are implementing a unique methodology using a series of N-of-1 or single subject randomized, double blind, controlled studies. With this, we will explore the role of soy protein supplementation in neuropathic pain patients. Each patient will be exposed in 3-week intervals to soy protein and a control, milk protein, in three paired treatment periods for a total of 18 weeks. This method allows for the measurement of treatment efficacy in individual distinct patients and has the potential for immediate and continued medical benefit using a simple and readily available dietary ingredient.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Soy Protein | Experimental | 30g of soy protein from whole soybean soymilk powder given daily for 3 weeks |
|
| Milk Protein | Placebo Comparator | 30g of milk protein from whole milk powder given daily for 3 weeks |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Whole soybean soymilk powder | Dietary Supplement |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| Pain Intensity | Baseline and 3 times during the last week of every treatment period |
| Measure | Description | Time Frame |
|---|---|---|
| Pain Quality | Baseline and 3 times during the last week of every treatment period | |
| Dynamic tactile allodynia | Baseline and at the end of every treatment period | |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Yoram Shir, MD | McGill University Health Centre/Research Institute of the McGill University Health Centre | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| McGill University Health Centre | Montreal | Quebec | H3G 1A4 | Canada |
Not provided
| ID | Term |
|---|---|
| D009437 | Neuralgia |
| ID | Term |
|---|---|
| D010523 | Peripheral Nervous System Diseases |
| D009468 | Neuromuscular Diseases |
| D009422 | Nervous System Diseases |
| D010146 | Pain |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Whole milk powder | Dietary Supplement |
|
|
| Area of dynamic allodynia |
| Baseline and at the end of every treatment period |
| Quality of life | Baseline and at the end of every treatment period |
| Depression | Baseline and at the end of every treatment period |
| Dietary intake | Baseline, once a week during the first treatment period, once during the second week of the remaining treatment periods. |
| Body weight | Baseline and at the end of every treatment period |
| Analgesic medication use | Baseline and 3 times during the last week of every treatment period |
| Adverse events | The full 18 weeks until the end of the last treatment period |
| D009461 |
| Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |